Windar Photonics Raises $7.0M Funding

Aisel Health

Psychiatry doesn't need generic technology bolted onto an overburdened workflow. It needs a product built for the realities of psychiatric care - where clinicians bring judgment and trained intuition, and technology brings the speed and structure to hold together every detail no human memory can. Aisel Health builds software that helps psychiatric clinics scale their operations by surfacing the right information in front of clinicians exactly when it matters most. This improves the patient experience, reduces strain on staff, and increases clinic profitability. Better access to patient information means faster, better care. Our vision: a future where clinicians don't spend their years of psychiatric training searching and writing, but practising psychiatry at its highest level - understanding patients, making sound clinical judgments, and caring for the millions of patients waiting to get help. Built with psychiatrists, for psychiatry. Privacy-first, GDPR-compliant, and hosted entirely in the EU. Interested in scaling your clinic with Aisel? 👉 Register: www.aisel.co

Quadric

Quadric is a strategic consulting team and the developer of Quadric Network (quadric.net), a community for the people behind brands. Our consultants help international companies increase differentiation and drive growth. Companies usually hire us at times of significant change such as when developing a new strategy, integrating acquisitions or addressing an increasing competitive threat. We are known for running projects efficiently, working closely with in-house teams, and ensuring recommendations get implemented. Based in Copenhagen, we work with clients in a wide range of countries and industries. Browse our cases to get a sense of our experience (quadric.dk/cases/). For consulting inquiries, please contact Mark Ronan (+45 26 28 90 80).

Acesion Pharma

Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting SK ion channels.